Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.

Saved in:
Bibliographic Details
Title: Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
Authors: Villanueva V; Refractory Epilepsy Unit, Hospital Universitario y Politécnico La Fe, EpiCARE member, Avenida Fernando Abril Martorell 106, 46026, Valencia, Spain. villanueva_vichab@gva.es., Laloyaux C; UCB Pharma, Brussels, Belgium., D'Souza W; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Melbourne, Australia., Faught E; Emory Epilepsy Center, Atlanta, GA, USA., Klein P; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA., Reuber M; The University of Sheffield, Sheffield, UK., Rosenow F; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Center of Neurology and Neurosurgery, Frankfurt am Main, Germany., Salas-Puig J; Universitari Vall d'Hebron, Barcelona, Spain., Insuga VS; Pediatric Neurology, Hospital Universitario Infantil Niño Jesús, Madrid, Spain., Strzelczyk A; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Center of Neurology and Neurosurgery, Frankfurt am Main, Germany., Szaflarski JP; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Department of Neurology and UAB Epilepsy Center, Birmingham, AL, USA., Chinn C; UCB Pharma, Slough, England, UK., Daniels T; UCB Pharma, Morrisville, NC, USA., Floricel F; UCB Pharma, Monheim am Rhein, Germany., Friesen D; UCB Pharma, Slough, England, UK., Sendersky V; UCB Pharma, Brussels, Belgium., Besson H; UCB Pharma, Breda, The Netherlands., Steinhoff BJ; Kork Epilepsy Center, Kehl-Kork and Medical Faculty, University of Freiburg, Freiburg, Germany.
Source: CNS drugs [CNS Drugs] 2023 Sep; Vol. 37 (9), pp. 819-835. Date of Electronic Publication: 2023 Sep 09.
Publication Type: Review; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37684497
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Villanueva+V%22">Villanueva V</searchLink>; Refractory Epilepsy Unit, Hospital Universitario y Politécnico La Fe, EpiCARE member, Avenida Fernando Abril Martorell 106, 46026, Valencia, Spain. villanueva_vichab@gva.es.<br /><searchLink fieldCode="AU" term="%22Laloyaux+C%22">Laloyaux C</searchLink>; UCB Pharma, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22D'Souza+W%22">D'Souza W</searchLink>; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Faught+E%22">Faught E</searchLink>; Emory Epilepsy Center, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Klein+P%22">Klein P</searchLink>; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Reuber+M%22">Reuber M</searchLink>; The University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Rosenow+F%22">Rosenow F</searchLink>; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Center of Neurology and Neurosurgery, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Salas-Puig+J%22">Salas-Puig J</searchLink>; Universitari Vall d'Hebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Insuga+VS%22">Insuga VS</searchLink>; Pediatric Neurology, Hospital Universitario Infantil Niño Jesús, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Strzelczyk+A%22">Strzelczyk A</searchLink>; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Center of Neurology and Neurosurgery, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Szaflarski+JP%22">Szaflarski JP</searchLink>; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Department of Neurology and UAB Epilepsy Center, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Chinn+C%22">Chinn C</searchLink>; UCB Pharma, Slough, England, UK.<br /><searchLink fieldCode="AU" term="%22Daniels+T%22">Daniels T</searchLink>; UCB Pharma, Morrisville, NC, USA.<br /><searchLink fieldCode="AU" term="%22Floricel+F%22">Floricel F</searchLink>; UCB Pharma, Monheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Friesen+D%22">Friesen D</searchLink>; UCB Pharma, Slough, England, UK.<br /><searchLink fieldCode="AU" term="%22Sendersky+V%22">Sendersky V</searchLink>; UCB Pharma, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Besson+H%22">Besson H</searchLink>; UCB Pharma, Breda, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Steinhoff+BJ%22">Steinhoff BJ</searchLink>; Kork Epilepsy Center, Kehl-Kork and Medical Faculty, University of Freiburg, Freiburg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229431220%22">CNS drugs</searchLink> [CNS Drugs] 2023 Sep; Vol. 37 (9), pp. 819-835. <i>Date of Electronic Publication: </i>2023 Sep 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Review; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9431220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211727047%22">11727047 </searchLink><i>NLM ISO Abbreviation: </i>CNS Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37684497
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40263-023-01033-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 819
    Titles:
      – TitleFull: Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Villanueva V
      – PersonEntity:
          Name:
            NameFull: Laloyaux C
      – PersonEntity:
          Name:
            NameFull: D'Souza W
      – PersonEntity:
          Name:
            NameFull: Faught E
      – PersonEntity:
          Name:
            NameFull: Klein P
      – PersonEntity:
          Name:
            NameFull: Reuber M
      – PersonEntity:
          Name:
            NameFull: Rosenow F
      – PersonEntity:
          Name:
            NameFull: Salas-Puig J
      – PersonEntity:
          Name:
            NameFull: Insuga VS
      – PersonEntity:
          Name:
            NameFull: Strzelczyk A
      – PersonEntity:
          Name:
            NameFull: Szaflarski JP
      – PersonEntity:
          Name:
            NameFull: Chinn C
      – PersonEntity:
          Name:
            NameFull: Daniels T
      – PersonEntity:
          Name:
            NameFull: Floricel F
      – PersonEntity:
          Name:
            NameFull: Friesen D
      – PersonEntity:
          Name:
            NameFull: Sendersky V
      – PersonEntity:
          Name:
            NameFull: Besson H
      – PersonEntity:
          Name:
            NameFull: Steinhoff BJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2023 Sep
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1934
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: CNS drugs
              Type: main
ResultId 1